O'Connell Mj
Impact in
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 5
- Cancer Diagnosis and Treatment 2
-
- Biochemical and Molecular Research 4
- Co-authors
- Beart Rw (1 shared paper)Moertel Cg (12 shared papers)Robert G. Hahn (9 shared papers)Joseph Rubin (1 shared paper)Eagan Rt (3 shared papers)Schutt Aj (8 shared papers)Edmonson Jh (6 shared papers)Stephen Frytak (7 shared papers)
- Journals
- PubMed (35 papers)
- Partner nations
- United States
In The Last Decade
O'Connell Mj
33 papers receiving 297 citations
Peers
Comparison fields: 5 of 60
- Oncology 186
- Pathology and Forensic Medicine 50
- Cancer Research 32
- Neurology 31
- Toxicology 7
Countries citing papers authored by O'Connell Mj
This map shows the geographic impact of O'Connell Mj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O'Connell Mj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O'Connell Mj more than expected).
Fields of papers citing papers by O'Connell Mj
This network shows the impact of papers produced by O'Connell Mj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O'Connell Mj. The network helps show where O'Connell Mj may publish in the future.
Co-authors
The 25 scholars most cited alongside O'Connell Mj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Postoperative follow-up of patients with carcinoma of the colon. | 1983 | 65 |
| 2 | Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. | 1986 | 31 |
| 3 | Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination. | 1983 | 31 |
| 4 | Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer. | 1976 | 22 |
| 5 | High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group. | 1985 | 16 |
| 6 | Phase I study of N-(phosphonacetyl)-L-aspartic acid (PALA). | 1980 | 15 |
| 7 | Phase II trial of maytansine in patients with advanced colorectal carcinoma. | 1978 | 10 |
| 8 | Is hepatic infusion of chemotherapy effective treatment for liver metastases? No! | 1992 | 10 |
| 9 | Evaluation of a fixed alternating treatment in patients with advanced breast cancer. | 1978 | 9 |
| 10 | Pancreatic cancer in the older patient. | 2001 | 9 |
| 11 | Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer. | 1987 | 9 |
| 12 | Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group study. | 1984 | 8 |
| 13 | Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy. | 1978 | 8 |
| 14 | Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma. | 1976 | 8 |
| 15 | Value of preoperative radionuclide bone scan in suspected primary breast carcinoma. | 1978 | 8 |
| 16 | Early clinical trial of a 1-day intermittent schedule for pentamethylmelamine. | 1981 | 8 |
| 17 | Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer. | 1984 | 8 |
| 18 | Pilot study of two adriamycin-based regimens in patients with advanced malignant lymphomas. | 1977 | 7 |
| 19 | Lymphocytic lymphoma involving the middle ear. | 1980 | 6 |
| 20 | Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas. | 1980 | 6 |
About O'Connell Mj
O'Connell Mj is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Neurology, having authored 35 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Biochemical and Molecular Research (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Neuroblastoma Research and Treatments (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (186 citations), Pathology and Forensic Medicine (50 citations), Cancer Research (32 citations), Neurology (31 citations) and Toxicology (7 citations). O'Connell Mj has collaborated with scholars based in United States. Frequent co-authors include Beart Rw, Moertel Cg, Robert G. Hahn, Joseph Rubin, Eagan Rt, Schutt Aj, Edmonson Jh, Stephen Frytak, Joshua T. Rubin and Kvols Lk. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.